CBER
Sipuleucel-T
BLA 125197
FDA Clinical Review and Findings
Ke Liu, MD, PhD
Clinical Reviewer
Division of Clinical Evaluation, Pharmacology and
Toxicology
(DCEPT), OCTGT, CBER, FDA
March 29, 2007
Cellular, Tissue and Gene Therapies Advisory Committee Meeting
1